翰思艾泰生物医药科技（武汉）股份有限公司（股票代码：03378）于2026年4月16日发布公告，披露回购股份事宜。
公司于2026年4月16日在香港联交所场内回购20,100股H股，约占当日已发行股本0.015%。每股回购价格介乎28.48港元至30港元不等，总费用约为59.07万港元（折合590,668港元）。
本次回购完成后，公司已发行股本变动为135,997,930股，库藏股数量增至220,900股。回购授权于2026年2月12日获股东大会通过，可回购股份总数上限为13,621,883股。公司确认已遵守所有适用法律法规及香港联交所上市规则的规定。
本公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.